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monitored with Calypso (Varian) for gating and tracking 
treatments, and compensated with the PerfectPitch couch 
(Varian) for tracking. The dose in the moving tumor was 
measured with Gafchromic EBT2 (ISP) films. Changes in 
homogeneity indices (ΔH1-99) between the films and the 
planned dose distributions and their gamma agreement 
scores using 3%/3mm (GS3%/3mm) were evaluated. The film 
areas receiving more than the planned minimum dose 
(A>Dmin) were calculated. OAR doses from the treatment 
plans were compared. 
 
Results: The results for each MMT are summarized in Table 1, 
giving the median values with 25% and 75% percentiles over 
the five measurements with different respiration patterns. 
All techniques achieved a good coverage of the tumor. 
Median values for A>Dmin were above 99% for all techniques 
and ITV and MidV concepts showed lower gamma agreement 
scores (median: 88.9% and 87.7%) compared to gating and 
tracking (94.2% and 94.8%). For ITV and MidV concepts larger 
increases in inhomogeneity were found (median: 4.3 and 5.6 
percentage points respectively) than for gating and tracking 
(2.8 and 2.3). Gating and tracking were able to reduce OAR 




Conclusion: Tracking and gating showed a superior 
agreement with the planned dose distribution and at the 
same time reduced the dose to OAR in comparison to the 
passive motion management techniques. 
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Purpose or Objective: Hypofractionated SBRT is an effective 
low-toxic therapy option for liver metastases. In our 
department, liver SBRT is performed in DIBH with ABC (Active 
Breathing coordinator) and image-guidance with breath-hold 
CBCT. For additional monitoring of the movable target 
and/or surrogate structures, an ultrasound-based tracking 
system has been developed. We evaluated the feasibility and 
the accuracy of this system on a motion phantom and healthy 
volunteers. 
 
Material and Methods: The tracking accuracy of a 4D 
ultrasound system (Clarity Anticosti, Elekta, Sweden) was 
evaluated using an ultrasound phantom (BAT, Nomos) and a 
motion platform (CIRS, USA) with different settings to obtain 
optimal parameters to track structures moving with 
respiration. An initial evaluation was performed with 5 
healthy volunteers to assess the performance in a quasi-
clinical setting. An ultrasound dataset was acquired in ABC-
based breath hold (breath hold time 20 sec, free breathing 
phases of 5-6 breathing cycles). Tracked structures were 
renal pelvis as a centroid structure and a portal vein/liver 
vein as a non-centroid structure. The scanning range of the 
ultrasound probe was varied. The motion component in 
superior-inferior direction was compared with the motion of 
an external marker on the body surface and the data from 
ABC. 
 
Results: a) Phantom data: The tracking accuracy increased 
with decreasing scanning range. For a cycle time (sinusoidal 
motion) of 10 s and an amplitude of 10 mm, the mean and 
standard deviation of differences between the measured and 
the reference position values were 0.57 + 0.48 mm and 0.31 
+ 0.20 mm in 15° and 5° scanning range respectively,while 
for a cycle time of 5 s were 1.33 + 1.20 mm and 0.34 + 0.25 
mm for 8° and 4° scanning range respectively. For a fixed 
scanning range, the accuracy of ultrasound tracking 
decreased with a decrease of cycle times. 
b) Volunteer data: The system’s tracking success rate was 
90.77% of all breath-hold phases.The renal pelvis tracking 
success rate was 95.42%, while 86.79% for portal vein.A 
compromise between scanning range and cycle times had to 
be established depending on target. A working scanning range 
was between 10°-40°. For angles <10°there is a higher risk 
that the target is sometimes outside the ultrasound. This will 
lead to a reduced tracking success rate. Tracking curves (SI 
direction)were in good accordance with breathing curves of 
ABC and a fiducial placed on the infradiaphragmatic 
abdominal wall. 
 
Conclusion: The ultrasound system showed good 
performance on a motion phantom and healthy volunteers. A 
positioning setup that provides good ultrasound visual over a 
long period in clinical environment could be established. 
Further improvement of the tracking algorithm could improve 
accuracy along with respiratory motion if using large scanning 
angles for detection of high-amplitude motion and non-linear 
transformations of the tracking target. 
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Purpose or Objective: The emergence of hypofractionated 
protocols in prostate cancer treatment requires a better 
accuracy in dose delivery because of an increased risk of 
toxicity to the safe tissues. The aim of this study was to 
evaluate intrafraction motions of the target volumes for 
prostate cancer patients imaged with a new transperineal 
ultrasound (TP-US) device. 
 
Material and Methods: The accuracy of the tracking of the 
TP-US (Clarity®, Elekta, Stockholm, Sweden) probe was first 
investigated by comparing the measured positions of a target 
volume in a phantom with the Clarity device and the 
simultaneous use of a transmitter based positioning device 
(RayPilot, Micropos Medical, Sweden). Then intra-fraction 
motions measured with the TP-US were analyzed for 13 
prostate patients (426 sessions) and 14 post-prostatectomy 
patients (438 sessions). The fraction of time that the target 
volume was displaced by more than 3 and 5 mm was 
calculated for tracking times ranging between 60-420s, for 
each session and each patient. The mean displacements were 
also calculated for each direction. Percentages of sessions for 
which thresholds of 3 mm and 5 mm were exceeded during 15 
s and 30 s in each direction were determined. 
 
Results: Differences between TP-US and transmitter based 
devices were below 1.5 mm for all directions. The observed 
motions were patients and sessions dependent and increased 
with the treatment time. During the first minute, 3D 
displacements above 3 mm were seen 5% and 1.9% of the 
time, for prostate and post-prostatectomy patients, 
respectively while they reached 38% and 10.8% of the time 
after 7 min of treatment. Maximum 3D displacements above 5 
mm were observed after 7 min 11.6% and 1.6% of the time for 
prostate and post-prostatectomy patients, respectively. Mean 
displacements in AP, SI and LR directions were -0.9±0.8mm, 
0.9±0.8mm and -0.3±0.5mm for prostate patients and -
0.9±0.5mm, 0.2±0.4mm and 0.1±0.4mm for post-
prostatectomy patients. The maximum percentage of sessions 
for which the prostate and post-prostatectomy volumes 
exceeded the 3 mm tracking limits for at least 15 s was 
observed in the AP direction (Table 1). Conversely, minimum 
